Grant Programs for
Sarcoma Research & Education
Investing in the
Future of Sarcoma Care
Rein in Sarcoma supports innovative research that drives earlier diagnosis, stronger treatment options, and better outcomes for patients and families. Through our competitive grant programs, we provide funding to researchers, students, and institutions who are dedicated to moving sarcoma science forward.
This work is made possible through the generosity of our donors, sponsors, and volunteers. Their support fuels discoveries that bring hope to families today and shape a brighter future for those affected by sarcoma.
Funding
Outcomes
Since 2001, Rein In Sarcoma has funded more than $2 million in research and education at leading institutions such as:
University of Minnesota
Rein in Sarcoma supports research at the University of Minnesota that aims to improve sarcoma diagnosis, treatment, and long-term outcomes for patients of all ages.
Mayo Clinic
Our funding helps Mayo Clinic investigators advance innovative approaches to sarcoma care through clinical research and scientific discovery.
University of Calgary
Through the Kasey Altman Research Fund, Rein in Sarcoma contributes to groundbreaking studies at the University of Calgary that explore new ways to understand and treat rare sarcoma subtypes.
Children’s Hospital and Clinics of Minnesota
We partner with Children’s Minnesota to support research focused on improving treatment and survivorship for children and adolescents facing sarcoma.
SARC and other international collaborations
We proudly support SARC and global research partners working together to accelerate progress and bring new hope to sarcoma patients worldwide.
University of Minnesota
Rein in Sarcoma supports research at the University of Minnesota that aims to improve sarcoma diagnosis, treatment, and long-term outcomes for patients of all ages.
Mayo Clinic
Our funding helps Mayo Clinic investigators advance innovative approaches to sarcoma care through clinical research and scientific discovery.
University of Calgary
Through the Kasey Altman Research Fund, Rein in Sarcoma contributes to groundbreaking studies at the University of Calgary that explore new ways to understand and treat rare sarcoma subtypes.
Children’s Hospital and Clinics of Minnesota
We partner with Children’s Minnesota to support research focused on improving treatment and survivorship for children and adolescents facing sarcoma.
SARC and other international collaborations
We proudly support SARC and global research partners working together to accelerate progress and bring new hope to sarcoma patients worldwide.
SARC and other international collaborations
Item description – lobortis ac odio fringilla laoreet. Morbi hendrerit in massa eget ullamcorper. Donec nec sapien orci.
For Donors and Sponsors
Every grant is an investment in hope. Support from donors and sponsors makes it possible to fund meaningful research that has the potential to shape the future of sarcoma care. Your generosity helps fuel discoveries that bring comfort, progress, and possibility to patients and families.
Current Funding Programs
Since 2001, Rein in Sarcoma has invested more than $2 million in research and education, supporting leading institutions committed to improving sarcoma diagnosis, treatment, and patient care.
Applying For Grants
Rein In Sarcoma supports projects that advance understanding, improve treatment, and foster collaboration in sarcoma research.
Eligibility: Researchers, clinicians, and students with sarcoma-related proposals.
Focus Areas: Basic science, clinical research, translational projects, and community education.
Funding Cycle: Annual grant awards with proposals reviewed by scientific advisors and the Rein In Sarcoma board.
Rein In Sarcoma News
Stay Connected & Informed
Get the latest news, events, and sarcoma breakthroughs from Rein in Sarcoma, supporting patients, families, and research efforts.
Progress and Promise
Each funded project is a step forward. By connecting researchers, students, donors, and sponsors, Rein In Sarcoma’s grant programs foster discovery, collaboration, and progress — bringing us closer to a world without sarcoma.
